These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30411235)

  • 41. Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution.
    Oleksak P; Nepovimova E; Valko M; Alwasel S; Alomar S; Kuca K
    Environ Toxicol Pharmacol; 2024 Jun; 108():104447. PubMed ID: 38636744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pheromones: a new ergogenic aid in sport?
    Papaloucas M; Kyriazi K; Kouloulias V
    Int J Sports Physiol Perform; 2015 Oct; 10(7):939-40. PubMed ID: 25710097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Can furosemide mask the use of performance-enhancing drugs?].
    Brinkman DJ; Tichelaar J; Van Agtmael MA
    Ned Tijdschr Geneeskd; 2021 May; 165():. PubMed ID: 34346634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereoisomers in sports drug testing: Analytical strategies and applications.
    Thomas A; Thevis M
    J Chromatogr A; 2022 Jul; 1674():463154. PubMed ID: 35613502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review.
    McDuff D; Stull T; Castaldelli-Maia JM; Hitchcock ME; Hainline B; Reardon CL
    Br J Sports Med; 2019 Jun; 53(12):754-760. PubMed ID: 31097457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Doping agents and their analytical control].
    Szókán G
    Acta Pharm Hung; 2002; 72(4):231-44. PubMed ID: 12812043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Annual banned-substance review - Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2020 Jan; 12(1):7-26. PubMed ID: 31724288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry.
    Van Eenoo P; Van Gansbeke W; De Brabanter N; Deventer K; Delbeke FT
    J Chromatogr A; 2011 May; 1218(21):3306-16. PubMed ID: 20970803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The analytical chemistry of drug monitoring in athletes.
    Bowers LD
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
    Ahrens BD; Kucherova Y; Butch AW
    Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge.
    Gild ML; Stuart M; Clifton-Bligh RJ; Kinahan A; Handelsman DJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3562-e3573. PubMed ID: 35438767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2012 Jan; 4(1):2-16. PubMed ID: 22287289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of legal and illegal stimulating agents in sports.
    Deventer K; Roels K; Delbeke FT; Van Eenoo P
    Anal Bioanal Chem; 2011 Aug; 401(2):421-32. PubMed ID: 21479548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.
    Fitch K
    Clin Med (Lond); 2012 Jun; 12(3):257-60. PubMed ID: 22783779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of drugs to improve athletic performance].
    Kuipers H; Hartgens F
    Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Illicit drugs and cardiac arrhythmias in athletes.
    Furlanello F; Serdoz LV; Cappato R; De Ambroggi L
    Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):487-94. PubMed ID: 17667636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2011 Jan; 3(1):1-14. PubMed ID: 21254451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An anti-doping sampling strategy utilizing the sewerage systems of sport villages.
    Katsoyiannis A; Jones KC
    Environ Sci Technol; 2011 Jan; 45(2):362-3. PubMed ID: 21142144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.